Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Epidemics
Recent news which mentions Epidemics
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
25
26
Next >
WHO says omicron BA.2 subvariant will rise globally, but scientists don't know if it can reinfect people
February 08, 2022
Tags
Disease outbreaks
U/S/ Economy
Business News
From
CNBC.com News
Pfizer CEO says chances are 'very high' FDA will approve low-dose Covid shots for kids under 5
February 08, 2022
Tags
Politics
Biotechnology
Breaking News: Business
From
CNBC.com News
Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill
February 08, 2022
Tags
Business
Pandemics
World News
From
CNBC.com News
Though rare, Moderna Covid vaccine recipients have higher risk of heart inflammation than Pfizer
February 04, 2022
Tags
Pandemics
Business
World News
From
CNBC.com News
Moderna's Covid vaccine for teens awaits OK as regulators review heart inflammation risk
February 04, 2022
Tags
Business News
Johnson & Johnson
U/S/ Economy
From
CNBC.com News
Merck expects to sell $5 billion to $6 billion of its new Covid treatment pill in 2022
February 03, 2022
Tags
Health care industry
US Economy
US Top News and Analysis
From
CNBC.com News
Covid will always be an epidemic virus — not an endemic one, scientist warns
February 02, 2022
Tags
Vaccinations
Measles
Coronavirus
From
CNBC.com News
Pfizer starts submitting data for FDA emergency approval of vaccine for kids under 5
February 01, 2022
Tags
Biotech and Pharmaceuticals
US Economy
Health care industry
From
CNBC.com News
WHO says the new omicron subvariant doesn't appear to be more severe than the original
February 01, 2022
Tags
Biotechnology
Politics
Epidemics
From
CNBC.com News
The new omicron subvariant is more contagious, but vaccinated people are less likely to spread it, study finds
January 31, 2022
Tags
Pfizer Inc
Health & Science
US: News
From
CNBC.com News
The latest Covid variant is 1.5 times more contagious than omicron and already circulating in almost half of U.S. states
January 28, 2022
Tags
Pandemics
Business
World News
From
CNBC.com News
60 million U.S. households have ordered free Covid tests, White House says
January 28, 2022
Tags
Disease outbreaks
U/S/ Economy
Business News
From
CNBC.com News
Moderna starts clinical trial of booster shot targeting omicron Covid variant
January 26, 2022
Tags
Epidemics
Coronavirus
Breaking News: Business
From
CNBC.com News
The next Covid variant will be more contagious than omicron, but the question is whether it will be more deadly, WHO says
January 25, 2022
Tags
Breaking News: Business
Policy
Epidemics
From
CNBC.com News
Biden administration withdraws Covid vaccine mandate for businesses after losing Supreme Court case
January 25, 2022
Tags
Health & Science
US: News
World News
From
CNBC.com News
J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
January 25, 2022
Tags
US Top News and Analysis
Biotech and Pharmaceuticals
U/S/ Markets
From
CNBC.com News
Pfizer and BioNTech launch clinical study of Covid vaccine targeting omicron
January 25, 2022
Tags
Pandemics
Business
US: News
From
CNBC.com News
Two years since Covid was first confirmed in U.S., the pandemic is worse than anyone imagined
January 21, 2022
Tags
Politics
Biotechnology
Breaking News: Business
From
CNBC.com News
Children under 5 are not eligible for Covid vaccination. Doctors have this advice to protect them during the omicron surge
January 21, 2022
Tags
Children
Disease outbreaks
COVID/19
From
CNBC.com News
Kids' Covid hospitalizations hit pandemic high, worrying doctors and parents about long-term impact
January 21, 2022
Tags
Business
World News
Vaccinations
From
CNBC.com News
Fauci says FDA could authorize Pfizer's Covid vaccine for kids under 5 in the next month
January 19, 2022
Tags
US: News
World News
Business
From
CNBC.com News
Biden will make 400 million N95 masks available to Americans for free
January 19, 2022
Tags
World News
US: News
Pandemics
From
CNBC.com News
Some Americans blocked from ordering Biden's free Covid tests in early website launch
January 18, 2022
Tags
Biotechnology
Politics
Breaking News: Business
From
CNBC.com News
WHO says omicron won't be last Covid variant as global cases surge by 20% in a week
January 18, 2022
Tags
Business News
U/S/ Economy
Disease outbreaks
From
CNBC.com News
Labor Department vows to protect workers from Covid after Supreme Court blocks business vaccine mandate
January 14, 2022
Tags
Health care industry
US Economy
US Top News and Analysis
From
CNBC.com News
GE suspends Covid vaccine and testing rules after Supreme Court blocks Biden mandate
January 14, 2022
Tags
World News
US: News
Business
From
CNBC.com News
Biden says U.S. to provide high quality masks for free to Americans
January 13, 2022
Tags
Health & Science
World News
US: News
From
CNBC.com News
Biden deploys military medical teams to hospitals in six states as omicron disrupts essential services
January 13, 2022
Tags
Politics
Biotechnology
Coronavirus
From
CNBC.com News
Omicron cases are less severe, hospital stays shorter than delta at large California health system
January 12, 2022
Tags
Biotech and Pharmaceuticals
US Top News and Analysis
Health care industry
From
CNBC.com News
Omicron disrupts transit, emergency services as workers call out sick: 'Most people are going to get Covid'
January 12, 2022
Tags
Epidemics
Coronavirus
Breaking News: Business
From
CNBC.com News
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.